Steven Cohen’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Steven Cohen's BLTE Position: Q3 2026 in Review
Steven Cohen reduced its Belite Bio (BLTE) stake by 63% in Q3 2026, selling an estimated $5.2M and leaving 19,143 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2091.
Steven Cohen first reported a position in BLTE in Q4 2023 and has held it in 9 quarters since. The position peaked at $45.5M in Q4 2025. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Steven Cohen held 19,143 shares of Belite Bio worth $3.25M as of Q3 2026.
- Steven Cohen sold 32,043 Belite Bio shares in Q3 2026, an estimated $5.2M.
- Belite Bio made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2091 holding.
- Steven Cohen first reported a position in Belite Bio in Q4 2023 and has held it in 9 quarters since.
- Steven Cohen's Belite Bio position peaked at $45.5M in Q4 2025.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.